US92686J1060 - Common Stock
/PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies...
These three biotech stocks are leading the sector higher on upbeat news but is this as good as it gets or do they have more gas in the tank?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors looking for a white-knuckle ride can easily find one by buying b...
There's no guarantee these stocks will double by 2030, but their growth prospects look great.
For investors looking for a way to play weight-loss stocks in this current backdrop, here are three top options to consider right now.
Capitalize on the biotech sector's boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks can offer some of the most explosive, exciting opportunities on ...
These rising drugmakers have serious arguments in their favor.
Viking Therapeutics has garnered a lot of attention following a successful clinical trial for its obesity care drug. But another development-stage biotech may have a superior candidate.
Shares of the clinical-stage biotech have skyrocketed on recent good news.
Viking Therapeutics stock is on fire following a successful phase 2 trial for its obesity care candidate.
These businesses should see good times ahead.
The drugmaker isn't losing momentum.
Its long-term growth potential looks like it's improving, again.
These two healthcare stocks should have plenty of room to run.
Viking shares have soared recently on optimism about its program.
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips What has been the top-performing stock so far of 2024? If you had said serve...
With interest rates poised to fall, acquisitions will become more numerous. Here are three potential takeover targets.
There is a plausible path for this biotech stock to make some investors millionaires.
Biotech is one of the hottest sectors on the market, creating big opportunities for some of the best biotech stocks to buy in April.
The company's experimental new weight-management drug looks great so far.
Viking Therapeutics may be the next company to enter the red-hot weight loss space.
Whether you're looking for high-powered growth or stable passive income, this basket of top stocks has it all.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The Russell 2000 index offers investors various small-cap companies that can in...